Chronic Spontaneous Urticaria Market is segmented By Treatment (H1-antihistamines, H2 antihistamines, Monoclonal Antibodies, Corticosteroids, Leukotriene Receptor Antagon ....
The major players operating in the chronic spontaneous urticaria market include Roche, Novartis, Sanofi/Regeneron, AstraZeneca, Amgen, Taiho Pharmaceutical, and other smaller players.
Chronic Spontaneous Urticaria Market